This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Sarnova Acquires DXE Medical, Inc.

"With this newest acquisition, Sarnova is uniquely positioned as a provider that can offer health care providers a comprehensive portfolio of clinically differentiated medical products and expertise supported by refurbishment, maintenance and repair services," said Chris Sweeney, a partner with Water Street and board member of Sarnova.  "We will continue to pursue new opportunities that will expand the company's capabilities to support customers with maximizing their spending on products and services that provide them with the highest quality and value."

DXE was a privately negotiated transaction.  Financial terms are not being disclosed.

About Sarnova, Inc. Sarnova is a leading specialty provider of health care products across the emergency medical services (EMS) and acute care continuum. It is comprised of three major business units: Bound Tree Medical, Emergency Medical Products, Inc. (EMP) and Tri-anim Health Services, Inc. Both Bound Tree and EMP are focused on EMS and pre-hospital medical supplies, while Tri-anim specializes in acute care and respiratory products. Together, Sarnova offers more than 100,000 health care products to thousands of emergency care providers, hospitals and advanced patient-care facilities nationwide. Sarnova is a company of Water Street Healthcare Partners, a strategic private equity firm focused exclusively on health care. For more information, visit www.sarnova.com.

SOURCE Sarnova, Inc.

Copyright 2011 PR Newswire. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.
2 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Try it NOW
Only $9.95
Try it NOW
14-Days Free
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG

Markets

DOW 17,688.61 +10.38 0.06%
S&P 500 2,058.62 +2.47 0.12%
NASDAQ 4,879.4420 +16.08 0.33%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs